Michael Huß

3.9k total citations
77 papers, 2.5k citations indexed

About

Michael Huß is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Michael Huß has authored 77 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Psychiatry and Mental health, 34 papers in Clinical Psychology and 22 papers in Cognitive Neuroscience. Recurrent topics in Michael Huß's work include Attention Deficit Hyperactivity Disorder (48 papers), Child and Adolescent Psychosocial and Emotional Development (27 papers) and Neural and Behavioral Psychology Studies (11 papers). Michael Huß is often cited by papers focused on Attention Deficit Hyperactivity Disorder (48 papers), Child and Adolescent Psychosocial and Emotional Development (27 papers) and Neural and Behavioral Psychology Studies (11 papers). Michael Huß collaborates with scholars based in Germany, United States and Switzerland. Michael Huß's co-authors include Manuela Stauss‐Grabo, Andreas Hahn, Jan Philipp Schuchardt, Heike Hölling, Robert Schlack, Ulrike Lehmkuhl, Carmen Maria Olivera Müller, Stefanie Wagner, André Tadić and Isabella Helmreich and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Michael Huß

73 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Huß Germany	25	1.7k	968	784	281	233	77	2.5k
Marsha D. Rappley United States	13	1.1k 0.6×	517 0.5×	385 0.5×	259 0.9×	167 0.7×	24	1.5k
Tim Wigal United States	27	2.7k 1.6×	1.6k 1.6×	919 1.2×	617 2.2×	238 1.0×	50	3.7k
Marco Battaglia Italy	33	595 0.4×	533 0.6×	1.2k 1.5×	183 0.7×	776 3.3×	83	2.6k
Mehdi Tehrani‐Doost Iran	21	570 0.3×	446 0.5×	450 0.6×	110 0.4×	91 0.4×	105	1.7k
Paramala Santosh United Kingdom	32	2.6k 1.6×	1.8k 1.9×	1.0k 1.3×	493 1.8×	284 1.2×	109	3.9k
Jill A. Hollway United States	19	1.2k 0.7×	1.2k 1.3×	610 0.8×	209 0.7×	112 0.5×	38	1.7k
Peter M. Wehmeier Germany	21	1.1k 0.7×	370 0.4×	594 0.8×	149 0.5×	197 0.8×	36	1.7k
Anne Halmøy Norway	24	1.5k 0.9×	772 0.8×	425 0.5×	214 0.8×	228 1.0×	54	2.0k
Christian Fleischhaker Germany	26	969 0.6×	338 0.3×	982 1.3×	65 0.2×	103 0.4×	83	1.8k
Christina Mohr Jensen Denmark	17	1.6k 1.0×	962 1.0×	816 1.0×	271 1.0×	163 0.7×	31	2.2k

Countries citing papers authored by Michael Huß

Since Specialization

Citations

This map shows the geographic impact of Michael Huß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Huß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Huß more than expected).

Fields of papers citing papers by Michael Huß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Huß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Huß. The network helps show where Michael Huß may publish in the future.

Co-authorship network of co-authors of Michael Huß

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Huß. A scholar is included among the top collaborators of Michael Huß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Huß. Michael Huß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huß, Michael, et al.. (2023). UHFB‐Overlay auf Fuß‐ und Radwegbrücke Karl‐Heine‐Bogen in Leipzig. Beton- und Stahlbetonbau. 118(9). 697–704. 2 indexed citations

Hautmann, Christopher, Christina Dose, Tobias Banaschewski, et al.. (2022). The importance of familial risk factors in children with ADHD: direct and indirect effects of family adversity, parental psychopathology and parenting practices on externalizing symptoms. Child and Adolescent Psychiatry and Mental Health. 16(1). 96–96. 5 indexed citations

Correll, Christoph U., et al.. (2021). Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients. CNS Spectrums. 1–13. 2 indexed citations

Coghill, David, et al.. (2020). Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses. European Child & Adolescent Psychiatry. 30(5). 809–821. 8 indexed citations

Lam, Alexandra P., Swantje Matthies, Erika Graf, et al.. (2019). Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms. JAMA Network Open. 2(5). e194980–e194980. 32 indexed citations

Huß, Michael, Bryan Dirks, Joan Gu, et al.. (2018). Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD. European Child & Adolescent Psychiatry. 27(10). 1283–1294. 17 indexed citations

Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2017). A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders. Journal of Child and Adolescent Psychopharmacology. 28(1). 47–54. 15 indexed citations

Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2017). Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients. Journal of Child and Adolescent Psychopharmacology. 27(6). 526–534. 15 indexed citations

Joseph, Alain, Rajeev Ayyagari, Meng Xie, et al.. (2017). Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison. European Child & Adolescent Psychiatry. 26(8). 875–897. 25 indexed citations

10.

Coghill, David, Alain Joseph, Vanja Sikirica, et al.. (2017). Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD. Journal of Attention Disorders. 23(13). 1578–1591. 18 indexed citations

11.

Kolar, David R., Michael Huß, Ekkehart Jenetzky, et al.. (2017). Momentary emotion identification in female adolescents with and without anorexia nervosa. Psychiatry Research. 255. 394–398. 11 indexed citations

12.

Hammerle, Florian, et al.. (2016). Thinking dimensional: prevalence of DSM-5 early adolescent full syndrome, partial and subthreshold eating disorders in a cross-sectional survey in German schools. BMJ Open. 6(5). e010843–e010843. 48 indexed citations

13.

Gajria, Kavita, Mark Kosinski, Vanja Sikirica, et al.. (2015). Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder. Health and Quality of Life Outcomes. 13(1). 184–184. 60 indexed citations

14.

Hervás, Amaia, Michael Huß, Mats Johnson, et al.. (2014). Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, Phase III trial. European Neuropsychopharmacology. 24(12). 1861–1872. 54 indexed citations

15.

Haessler, Frank, et al.. (2013). EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X Syndrome. BMC Psychiatry. 13(1). 339–339. 3 indexed citations

16.

Fleischhaker, Christian, Klaus Hennighausen, Philip Heiser, et al.. (2010). A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin ^® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting. Journal of Child and Adolescent Psychopharmacology. 20(5). 377–385. 20 indexed citations

17.

Bayerl, M. W., Thomas F. Dielentheis, Goran Vučurević, et al.. (2010). Disturbed brain activation during a working memory task in drug-naive adult patients with ADHD. Neuroreport. 21(6). 442–446. 36 indexed citations

18.

Schuchardt, Jan Philipp, Michael Huß, Manuela Stauss‐Grabo, & Andreas Hahn. (2009). Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Pediatrics. 169(2). 149–164. 228 indexed citations

19.

Holtmann, Martin, Sven Bölte, Manfred Döpfner, et al.. (2007). Prevalence of the Child Behavior Checklist‐pediatric bipolar disorder phenotype in a German general population sample. Bipolar Disorders. 9(8). 895–900. 66 indexed citations

20.

Kutcher, Stan, Michael G. Aman, Sarah J. Brooks, et al.. (2003). International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. European Neuropsychopharmacology. 14(1). 11–28. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact